Procept Biorobotics has been granted a patent for an apparatus for robotic surgery that customizes treatment plans based on patient data and surgical robotics data. The system aims to improve treatment outcomes by accommodating individual patient variability and surgical system parameters. GlobalData’s report on Procept Biorobotics gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
According to GlobalData’s company profile on Procept Biorobotics, AI-assisted surgical robots was a key innovation area identified from patents. Procept Biorobotics's grant share as of May 2024 was 18%. Grant share is based on the ratio of number of grants to total number of patents.
Robotic surgery apparatus for tissue removal with adjustable profile
A recently granted patent (Publication Number: US11963729B2) describes an innovative apparatus designed to remove tissue from a patient's organ. The apparatus includes a display and a processor that receives safety and efficacy parameters for the patient, an image of the organ, and then determines a removal profile based on these inputs. The removal profile, which may include protection zones for delicate tissue structures like the verumontanum of the prostate, is displayed on the screen. Users can adjust the removal profile through the interface, allowing for real-time updates of safety and efficacy parameters based on these adjustments.
The patent further details the apparatus's ability to display the organ image with the removal profile in various views, such as sagittal, transverse, and three-dimensional volumetric profiles. The processor can also identify delicate tissue structures, like cancerous tissue, within the organ and adjust protection zones accordingly. Additionally, the apparatus can utilize imaging techniques like fluoroscopy, CT scans, MRI, and more to enhance tissue margin identification and differentiation detection. Overall, this patented technology offers a sophisticated system for precise tissue removal procedures, ensuring optimal safety and efficacy parameters are maintained throughout the process.
To know more about GlobalData’s detailed insights on Procept Biorobotics, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
